7 results match your criteria: "Hospital Universitario Ruber Juan Bravo[Affiliation]"
Radiol Case Rep
January 2025
Radiology Department; Hospital Universitario QuironSalud Madrid, Diego de Velázquez 1, Pozuelo de Alarcón, España.
Rev Esp Enferm Dig
November 2024
Gastroenterology , Hospital Universitario Clínico San Carlos, Spain.
Background And Aims: large clinical trials and small real-world studies show that a 1-L polyethylene glycol and ascorbic acid solution (1-L PEG-ASC) is an effective and safe bowel preparation for colonoscopy. Here, the effectiveness and safety of 1-L PEG-ASC was evaluated in a large cohort of patients in routine clinical practice in Spain.
Methods: a sub-analysis was performed in an observational, multicenter, retrospective study assessing the effectiveness and safety of 1-L PEG-ASC in adult patients undergoing a colonoscopy at ten centers in Spain.
Med Clin (Barc)
August 2024
Servicio de Cirugía General, Visceral y Robótica, Hospital Universitario Ruber Juan Bravo, Madrid, España; Servicio de Patología, Hospital Universitario Ruber Juan Bravo, Madrid, España; Departamento de Medicina, Facultad de Ciencias Biomédicas y de la Salud, Universidad Europea de Madrid, Alcobendas, Madrid, España.
Introduction: Tumor budding (TB), defined as the presence of individual neoplastic cells or isolated groups of up to 4 cells at the front of tumor invasion, has become an adverse prognostic marker in colorectal cancer (CRC) in recent decades. The prognostic impact of TB in CRC remains not clearly defined and histological methods for its evaluation vary depending on the center. The objective of this study is to investigate the association between TB and CRC, in terms of oncological evolution and pathological stage.
View Article and Find Full Text PDFPacing Clin Electrophysiol
March 2024
Arrhythmia Unit, Cardiology Department, Hospital Universitario Quirón-Salud Madrid and Hospital Universitario Ruber Juan Bravo, Madrid, Spain.
J Pers Med
December 2023
Maxillofacial Surgery Department, Hospital Universitario Ruber Juan Bravo, 28006 Madrid, Spain.
Rev Neurol
December 2023
Findación CIEN. Instituto de Salud Carlos III, Madrid, España.
The detection by biomarkers of the pathophysiological and molecular processes involved in misfolding protein diseases making it possible to delineate the natural history of these processes. The great majority of protein misfolding diseases have a prolonged preclinical phase, in which the biological changes are patent. The clinical manifestations (i.
View Article and Find Full Text PDFCancers (Basel)
October 2023
Oral and Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Background: The American Joint Committee on Cancer (AJCC), in its 8th edition, introduces modifications to the previous TNM classification, incorporating tumour depth of invasion (DOI). The aim of this research is to analyse the prognosis (in terms of disease-free survival and overall survival) of clinical early stage (I and II) squamous cell carcinomas of the oral tongue according to the DOI levels established by the AJCC in its latest TNM classification to assess changes to the T category and global staging system and to evaluate the association between DOI and other histological risk factors.
Methods: A retrospective longitudinal observational study of a series of cases was designed.